Research Institute News
April 15, 2025
CancerCare Manitoba Announces Funding for Research in Manitoba
CancerCare Manitoba has announced new funding to support continued research into childhood cancer as youth transition into adulthood and leave the pediatric health care system. Collaborating with researchers in PROMISE — Pediatric Research in Oncology in Manitoba: Innovation, Science & Excellence — a province-wide pediatric cancer research initiative, this additional funding will help track and study youth after they turn 18.
New book from Institute researcher, Dignity in Care: The Human Side of Medicine helps shape the future of patient care
Senior Scientist at CancerCare Manitoba Research Institute, Dr. Harvey Max Chochinov has published a new book, Dignity in Care: The Human Side of Medicine, providing insight into how the disposition and attitude of healthcare providers indelibly shape patient experience.
New trial looks at reducing bleeding risk in cancer patients while also developing novel research methods
A new Investigator-Initiated Clinical Trial (IICT) led by Primary Investigator, Dr. Brett Houston, called the MYELO-CAN TXA trial, aims to see whether Tranexamic Acid (TXA) can help prevent bleeding in patients with certain blood cancers such as acute leukemia and myelodysplastic syndrome.
Advanced magnetic resonance simulator to bring new options for research and treatment
The Institute has acquired a state-of-the-art magnetic resonance simulator (MR-SIM) to be installed in 2024, made possible by generous community donations. The research applications of this technology will include new patient treatment techniques and workflows.
$17 million lab renovation enables research creativity and innovation
A major donation from the Paul Albrechtsen Foundation facilitates the transformation of 20-year-old research laboratories into state-of-the-art facilities housing cutting-edge technology and leading scientists pursuing the next cancer breakthroughs.
